Vita 34 AG buy kostojunior
Start price
25.04.26
/
70%
€4.47
Target price
25.04.27
€5.00
Performance (%)
-17.00%
Price
11.06.26
€3.82
Summary
This prediction is currently active. The prediction for Vita 34 AG disappoints with a performance of -17.00%. This prediction currently runs until 25.04.27. The prediction end date can be changed by kostojunior at any time. kostojunior has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vita 34 AG | -0.521% | -0.521% |
| iShares Core DAX® | 0,27 % | 2,50 % |
| iShares Nasdaq 100 | 1,88 % | 3,49 % |
| iShares Nikkei 225® | 3,58 % | 8,13 % |
| iShares S&P 500 | 0,15 % | 1,92 % |
According to kostojunior what are the pros and cons of Vita 34 AG for the foreseeable future?
Pros
Very Future proof/growth oriented business model
Market Leader or Top 3
Fair valuation
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
positive Cash Flow expected
Standard Investments for future growth
Well known brand
Cons
Comments by kostojunior for this prediction
In the thread Vita 34 AG diskutieren
Stopped prediction by kostojunior for Vita 34 AG
Vita 34 AG
Start price
Target price
Perf. (%)
€5.90
20.12.25
20.12.25
€7.00
20.12.26
20.12.26
4.24%
03.01.26
03.01.26
Very Future proof/growth oriented business model
Market Leader or Top 3
Fair valuation
EBIT growth >5% per year expected
Vita 34 AG
Start price
Target price
Perf. (%)
€4.80
20.07.25
20.07.25
-
20.07.26
20.07.26
2.92%
02.08.25
02.08.25
Very Future proof/growth oriented business model
Market Leader or Top 3
Fair valuation
EBIT growth >5% per year expected
Vita 34 AG
Start price
Target price
Perf. (%)
€4.28
15.04.25
15.04.25
€9.00
15.04.26
15.04.26
-0.47%
26.04.25
26.04.25
Very Future proof/growth oriented business model
Market Leader or Top 3
Fair valuation
EBIT growth >5% per year expected
Vita 34 AG
Start price
Target price
Perf. (%)
€4.76
19.09.23
19.09.23
€6.00
19.09.24
19.09.24
-1.68%
30.09.23
30.09.23
Very Future proof/growth oriented business model
Market Leader or Top 3
Fair valuation
EBIT growth >5% per year expected
Vita 34 AG
Start price
Target price
Perf. (%)
€4.79
07.09.23
07.09.23
-
07.09.24
07.09.24
-4.59%
16.09.23
16.09.23
Very Future proof/growth oriented business model
Market Leader or Top 3
Fair valuation
EBIT growth >5% per year expected
Vita 34 AG
Start price
Target price
Perf. (%)
€11.05
18.05.22
18.05.22
-
18.05.23
18.05.23
-0.45%
28.05.22
28.05.22
Very Future proof/growth oriented business model
Market Leader or Top 3
Fair valuation
EBIT growth >5% per year expected
Vita 34 AG
Start price
Target price
Perf. (%)
€15.55
21.02.21
21.02.21
-
21.02.22
21.02.22
-25.08%
22.02.22
22.02.22
Very Future proof/growth oriented business model
Market Leader or Top 3
Fair valuation
EBIT growth >5% per year expected
Vita 34 AG
Start price
Target price
Perf. (%)
€4.57
19.05.16
19.05.16
€4.99
21.11.16
21.11.16
8.32%
21.11.16
21.11.16
Very Future proof/growth oriented business model
Market Leader or Top 3
Fair valuation
EBIT growth >5% per year expected
Vita 34 AG
Start price
Target price
Perf. (%)
€4.60
18.03.16
18.03.16
€4.99
01.04.16
01.04.16
0.00%
01.04.16
01.04.16
Very Future proof/growth oriented business model
Market Leader or Top 3
Fair valuation
EBIT growth >5% per year expected
Vita 34 AG
Start price
Target price
Perf. (%)
€4.94
11.11.15
11.11.15
€5.55
01.12.15
01.12.15
2.25%
01.12.15
01.12.15
Very Future proof/growth oriented business model
Market Leader or Top 3
Fair valuation
EBIT growth >5% per year expected
Vita 34 AG
Start price
Target price
Perf. (%)
€5.24
08.09.15
08.09.15
€15.00
21.09.15
21.09.15
2.73%
21.09.15
21.09.15
Very Future proof/growth oriented business model
Market Leader or Top 3
Fair valuation
EBIT growth >5% per year expected
Vita 34 AG
Start price
Target price
Perf. (%)
€2.88
23.03.13
23.03.13
€4.44
23.09.13
23.09.13
-1.94%
23.09.13
23.09.13
Very Future proof/growth oriented business model
Market Leader or Top 3
Fair valuation
EBIT growth >5% per year expected